- Home
- CDNA vs BUI Comparison
CDNA vs BUI Comparison
Compare CDNA & BUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- BUI
- Stock Information
- Founded
- CDNA 1998
- BUI 2011
- Country
- CDNA United States
- BUI United States
- Employees
- CDNA N/A
- BUI N/A
- Industry
- CDNA Medical Specialities
- BUI Trusts Except Educational Religious and Charitable
- Sector
- CDNA Health Care
- BUI Finance
- Exchange
- CDNA Nasdaq
- BUI Nasdaq
- Market Cap
- CDNA 712.2M
- BUI 600.6M
- IPO Year
- CDNA 2014
- BUI N/A
- Fundamental
- Price
- CDNA $14.45
- BUI $26.41
- Analyst Decision
- CDNA Buy
- BUI
- Analyst Count
- CDNA 8
- BUI 0
- Target Price
- CDNA $26.86
- BUI N/A
- AVG Volume (30 Days)
- CDNA 1.3M
- BUI 59.8K
- Earning Date
- CDNA 11-03-2025
- BUI 01-01-0001
- Dividend Yield
- CDNA N/A
- BUI 6.79%
- EPS Growth
- CDNA N/A
- BUI N/A
- EPS
- CDNA 1.00
- BUI 2.75
- Revenue
- CDNA $340,826,000.00
- BUI N/A
- Revenue This Year
- CDNA $12.73
- BUI N/A
- Revenue Next Year
- CDNA $11.90
- BUI N/A
- P/E Ratio
- CDNA $14.57
- BUI $7.77
- Revenue Growth
- CDNA 14.72
- BUI N/A
- 52 Week Low
- CDNA $10.96
- BUI $18.73
- 52 Week High
- CDNA $31.52
- BUI $24.22
- Technical
- Relative Strength Index (RSI)
- CDNA 50.12
- BUI 47.77
- Support Level
- CDNA $13.95
- BUI $26.26
- Resistance Level
- CDNA $15.50
- BUI $27.33
- Average True Range (ATR)
- CDNA 0.55
- BUI 0.43
- MACD
- CDNA -0.10
- BUI 0.01
- Stochastic Oscillator
- CDNA 32.26
- BUI 43.67
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About BUI BlackRock Utility Infrastructure & Power Opportunities Trust
BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing of writing (selling) call and put options.